Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505. Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709. Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706. In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102. Case and Commentary Oct 2014 Sex Selection for Family Balancing Harry J. Lieman, MD and Andrzej K. Breborowicz, MD, PhD Should couples undergoing IVF be allowed to request sex selection for nonmedical so-called family balancing? Virtual Mentor. 2014;16(10):797-802. doi: 10.1001/virtualmentor.2014.16.10.ecas3-1410. Viewpoint Apr 2010 A Call for Collaborative Action against America’s Greatest Health Threat Richard H. Carmona, MD, MPH All of us who are pursuing solutions to the obesity epidemic face clinical, ethical, and regulatory challenges. First among them is the significant role of individual lifestyle and behavior choices in causing obesity. Virtual Mentor. 2010;12(4):327-330. doi: 10.1001/virtualmentor.2010.12.4.oped1-1004.
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.
Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709.
Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706.
In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102.
Case and Commentary Oct 2014 Sex Selection for Family Balancing Harry J. Lieman, MD and Andrzej K. Breborowicz, MD, PhD Should couples undergoing IVF be allowed to request sex selection for nonmedical so-called family balancing? Virtual Mentor. 2014;16(10):797-802. doi: 10.1001/virtualmentor.2014.16.10.ecas3-1410.
Viewpoint Apr 2010 A Call for Collaborative Action against America’s Greatest Health Threat Richard H. Carmona, MD, MPH All of us who are pursuing solutions to the obesity epidemic face clinical, ethical, and regulatory challenges. First among them is the significant role of individual lifestyle and behavior choices in causing obesity. Virtual Mentor. 2010;12(4):327-330. doi: 10.1001/virtualmentor.2010.12.4.oped1-1004.